Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  2. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  3. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  4. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  5. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  6. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  7. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  8. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  9. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  10. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  11. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  12. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  13. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  14. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  15. Mair F, et al. 2022. Nature. 605:728. PubMed
  16. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  17. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  18. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  19. Campisi L, et al. 2022. Nature. 606:945. PubMed
  20. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  21. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  22. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  23. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  24. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  25. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  26. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  27. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  28. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  29. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  30. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  31. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  32. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  33. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  34. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  35. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  36. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  37. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  38. Sun W, et al. 2023. Nature. 614:309. PubMed
  39. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  40. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  41. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  42. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  43. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  44. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  45. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  46. Wang CQ, et al. 2023. Cells. 12: . PubMed
  47. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  48. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  49. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  50. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  51. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  52. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  53. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  54. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  55. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  56. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  57. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  58. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  59. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  60. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  61. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  62. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  63. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  64. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  65. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  66. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  67. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  68. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  69. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  70. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  71. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  72. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  73. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  74. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  75. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  76. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  77. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  78. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  79. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  80. Li S, et al. 2022. Nature. 610:373. PubMed
  81. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  82. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  83. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  84. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  85. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  86. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  87. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  88. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  89. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  90. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  91. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  92. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  93. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  94. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  95. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  96. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  97. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  98. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  99. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  100. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  101. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  102. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  103. Gao F, et al. 2023. Immunity. 56:864. PubMed
  104. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  105. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  106. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  107. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  108. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  109. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  110. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  111. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  112. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  113. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  114. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  115. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  116. Solier S, et al. 2023. Nature. 617:386. PubMed
  117. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  118. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  119. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  120. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  121. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  122. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  123. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  124. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  125. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  126. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  127. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  128. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  129. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  130. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  131. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  132. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  133. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  134. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  135. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  136. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  137. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  138. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  139. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  140. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  141. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  142. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  143. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  144. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  145. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  146. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  147. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  148. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  149. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  150. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  151. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  152. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  153. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  154. Jairaman A, et al. 2022. Elife. 11:. PubMed
  155. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  156. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  157. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  158. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  159. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  160. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  161. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  162. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  163. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  164. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  165. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  166. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  167. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  168. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  169. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  170. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  171. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  172. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  173. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  174. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  175. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  176. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  177. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  178. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  179. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  180. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  181. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  182. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  183. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  184. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  185. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  186. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  187. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  188. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  189. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  190. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  191. Ogbe A, et al. 2022. JCI Insight. . PubMed
  192. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  193. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  194. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  195. Woodruff MC, et al. 2022. Nature. :. PubMed
  196. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  197. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  198. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  199. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  200. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  201. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  202. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  203. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  204. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  205. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  206. Kumar V, et al. 2022. Cells. 11:. PubMed
  207. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  208. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  209. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  210. Vijayakumar B, et al. 2022. Immunity. . PubMed
  211. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  212. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  213. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  214. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  215. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  216. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  217. Dogra P, et al. 2020. Cell. 749:180. PubMed
  218. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  219. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  220. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  221. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  222. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  223. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  224. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  225. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  226. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  227. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  228. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  229. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  230. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  231. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  232. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  233. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  234. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  235. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  236. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  237. Kreutmair S, et al. 2021. Immunity. . PubMed
  238. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  239. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  240. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  241. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  242. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  243. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  244. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  245. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  246. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  247. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  248. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  249. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  250. Romine KA, et al. 2021. Cancer Discov. . PubMed
  251. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  252. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  253. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  254. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  255. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  256. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  257. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  258. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  259. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  260. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  261. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  262. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  263. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  264. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  265. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  266. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  267. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  268. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  269. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  270. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  271. Thijssen R, et al. 2022. Blood. :. PubMed
  272. Good Z, et al. 2022. Nat Med. :. PubMed
  273. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  274. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  275. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  276. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  277. Shi J, et al. 2014. Blood. 123:4015. PubMed
  278. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  279. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  280. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  281. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  282. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  283. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  284. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  285. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  286. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  287. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  288. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  289. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  290. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  291. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  292. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  293. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  294. Woodruff M, et al. 2020. medRxiv. . PubMed
  295. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  296. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  297. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  298. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  299. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  300. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  301. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  302. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  303. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  304. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  305. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  306. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  307. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  308. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  309. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  310. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  311. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  312. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  313. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  314. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  315. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  316. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  317. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  318. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  319. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  320. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  321. Burns JC, et al. 2020. eLife. 9:00. PubMed
  322. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  323. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  324. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  325. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  326. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  327. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  328. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  329. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  330. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  331. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  332. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  333. Wang J, et al. 2022. iScience. 25:103971. PubMed
  334. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  335. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  336. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  337. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  338. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  339. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  340. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  341. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  342. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  343. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  344. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  345. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  346. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  347. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  348. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  349. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  350. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  351. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  352. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  353. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  354. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  355. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  356. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  357. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  358. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  359. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  360. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  361. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  362. Feng W, et al. 2020. J Vis Exp. . PubMed
  363. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  364. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  365. Song M, et al. 2018. Nature. 562:423. PubMed
  366. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  367. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  368. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  369. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  370. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  371. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  372. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  373. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  374. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  375. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  376. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  377. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  378. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  379. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  380. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  381. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  382. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  383. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  384. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  385. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  386. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  387. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  388. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  389. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  390. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  391. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  392. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  393. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  394. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  395. Georg P, et al. 2022. Cell. 185:493. PubMed
  396. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  397. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  398. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  399. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  400. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  401. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  402. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  403. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  404. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  405. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  406. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  407. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  408. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  409. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  410. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  411. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  412. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  413. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  414. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  415. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  416. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  417. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  418. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  419. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  420. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  421. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  422. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  423. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  424. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  425. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  426. Lederer K, et al. 2022. Cell. . PubMed
  427. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  428. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  429. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  430. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  431. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  432. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  433. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  434. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  435. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  436. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  437. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  438. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  439. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  440. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  441. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  442. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  443. Adamo S, et al. 2022. Nature. 602:148. PubMed
  444. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  445. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  446. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  447. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  448. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  449. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  450. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  451. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  452. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  453. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  454. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  455. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  456. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  457. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  458. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  459. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  460. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  461. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  462. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  463. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  464. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  465. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  466. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  467. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  468. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  469. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  470. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  471. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  472. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  473. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  474. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  475. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  476. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  477. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  478. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  479. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  480. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  481. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  482. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  483. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  484. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  485. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  486. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  487. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  488. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  489. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  490. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  491. Chen C, et al. 2022. iScience. 25:103645. PubMed
  492. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  493. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  494. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  495. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  496. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  497. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  498. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  499. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  500. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  501. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  502. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  503. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  504. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  505. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  506. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  507. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  508. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  509. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  510. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  511. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  512. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  513. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  514. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  515. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  516. Wang EY, et al. 2021. Nature. 595:283. PubMed
  517. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  518. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  519. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  520. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  521. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  522. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  523. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  524. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  525. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  526. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  527. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  528. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  529. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07.14.2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account